A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Recruiting

A ProSPEctivE Study of NGDS DMAT Workflow Feasibility

Who can join

Ages 21 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

1. Target lesions in the thorax or upper abdomen
2. Planned to undergo SBRT radiation treatment delivered on a conventional "C-arm" or ring gantry CBCT guided linear accelerator under breath hold conditions
3. ECOG performance status 0-1
4. At least 21 years of age
5. Able to sign informed consent

Exclusion Criteria:

1. Participants enrolled in another clinical investigation the investigator believes to be in conflict with this clinical investigation.
2. Participants with any other medical condition or laboratory value that would, at the discretion of the investigator, preclude the patient from participation in this clinical investigation.

About the study

The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.

What is being tested

Next Generation Delivery System (NGDS) (device)

Sponsor: Varian, a Siemens Healthineers Company · Participants: 20 · Started: Jul 31, 2026

Contact the study team

Jennifer Woo · Phone: 437-991-3496

Official record on ClinicalTrials.gov — NCT07824583

Locations in the U.S.

Missouri	Siteman Cancer Center Washington University, St Louis
Ohio	University Hospital Cleveland Medical Center, Cleveland

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.